参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/01 | 1,641 | 1,649 | 1,614 | 1,649 | +48 | +3% | 842,800 |
2021/10/29 | 1,605 | 1,608 | 1,582 | 1,601 | -5 | -0.3% | 821,300 |
2021/10/28 | 1,590 | 1,629 | 1,588 | 1,606 | -3 | -0.2% | 3,977,100 |
2021/10/27 | 1,608 | 1,618 | 1,601 | 1,609 | +11 | +0.7% | 1,160,900 |
2021/10/26 | 1,596 | 1,606 | 1,581 | 1,598 | +29 | +1.8% | 1,219,500 |
2021/10/25 | 1,575 | 1,582 | 1,564 | 1,569 | -17 | -1.1% | 616,200 |
2021/10/22 | 1,595 | 1,602 | 1,579 | 1,586 | -10 | -0.6% | 809,600 |
2021/10/21 | 1,635 | 1,635 | 1,594 | 1,596 | -48 | -2.9% | 760,700 |
2021/10/20 | 1,650 | 1,654 | 1,633 | 1,644 | +13 | +0.8% | 915,700 |
2021/10/19 | 1,621 | 1,646 | 1,601 | 1,631 | +75 | +4.8% | 1,709,300 |
2021/10/18 | 1,580 | 1,580 | 1,547 | 1,556 | -24 | -1.5% | 801,400 |
2021/10/15 | 1,557 | 1,581 | 1,551 | 1,580 | +40 | +2.6% | 945,200 |
2021/10/14 | 1,514 | 1,546 | 1,513 | 1,540 | +30 | +2% | 941,300 |
2021/10/13 | 1,508 | 1,525 | 1,505 | 1,510 | +14 | +0.9% | 1,114,300 |
2021/10/12 | 1,518 | 1,521 | 1,494 | 1,496 | -25 | -1.6% | 1,145,200 |
2021/10/11 | 1,491 | 1,524 | 1,477 | 1,521 | +8 | +0.5% | 994,700 |
2021/10/08 | 1,522 | 1,533 | 1,511 | 1,513 | +7 | +0.5% | 1,101,600 |
2021/10/07 | 1,513 | 1,514 | 1,497 | 1,506 | -6 | -0.4% | 642,800 |
2021/10/06 | 1,504 | 1,532 | 1,497 | 1,512 | +9 | +0.6% | 870,400 |
2021/10/05 | 1,520 | 1,533 | 1,501 | 1,503 | -32 | -2.1% | 854,000 |
2021/10/04 | 1,551 | 1,553 | 1,517 | 1,535 | -6 | -0.4% | 921,100 |
2021/10/01 | 1,570 | 1,571 | 1,528 | 1,541 | -35 | -2.2% | 915,900 |
2021/09/30 | 1,547 | 1,584 | 1,541 | 1,576 | +34 | +2.2% | 1,470,100 |
2021/09/29 | 1,550 | 1,554 | 1,528 | 1,542 | -38 | -2.4% | 1,109,700 |
2021/09/28 | 1,606 | 1,606 | 1,573 | 1,580 | -37 | -2.3% | 1,074,700 |
2021/09/27 | 1,636 | 1,640 | 1,613 | 1,617 | -18 | -1.1% | 778,900 |
2021/09/24 | 1,638 | 1,646 | 1,625 | 1,635 | +19 | +1.2% | 1,229,900 |
2021/09/22 | 1,622 | 1,637 | 1,608 | 1,616 | -4 | -0.2% | 934,200 |
2021/09/21 | 1,658 | 1,660 | 1,617 | 1,620 | -50 | -3% | 1,150,200 |
2021/09/17 | 1,679 | 1,682 | 1,661 | 1,670 | -8 | -0.5% | 1,631,100 |
2021/09/16 | 1,666 | 1,679 | 1,660 | 1,678 | +17 | +1% | 1,033,400 |
2021/09/15 | 1,680 | 1,680 | 1,655 | 1,661 | -31 | -1.8% | 1,483,800 |
2021/09/14 | 1,710 | 1,713 | 1,684 | 1,692 | -14 | -0.8% | 1,127,500 |
2021/09/13 | 1,691 | 1,707 | 1,676 | 1,706 | +6 | +0.4% | 780,300 |
2021/09/10 | 1,667 | 1,701 | 1,666 | 1,700 | +21 | +1.3% | 1,372,500 |
2021/09/09 | 1,687 | 1,704 | 1,674 | 1,679 | -16 | -0.9% | 759,500 |
2021/09/08 | 1,703 | 1,718 | 1,689 | 1,695 | -8 | -0.5% | 1,020,900 |
2021/09/07 | 1,697 | 1,712 | 1,691 | 1,703 | +18 | +1.1% | 1,092,100 |
2021/09/06 | 1,710 | 1,710 | 1,681 | 1,685 | -21 | -1.2% | 1,194,100 |
2021/09/03 | 1,678 | 1,717 | 1,673 | 1,706 | +33 | +2% | 1,271,000 |
2021/09/02 | 1,673 | 1,676 | 1,660 | 1,673 | +3 | +0.2% | 1,004,600 |
2021/09/01 | 1,642 | 1,672 | 1,642 | 1,670 | +30 | +1.8% | 970,300 |
2021/08/31 | 1,633 | 1,648 | 1,627 | 1,640 | +16 | +1% | 1,090,700 |
2021/08/30 | 1,610 | 1,624 | 1,600 | 1,624 | +16 | +1% | 797,900 |
2021/08/27 | 1,625 | 1,639 | 1,606 | 1,608 | -20 | -1.2% | 800,700 |
2021/08/26 | 1,624 | 1,640 | 1,615 | 1,628 | +5 | +0.3% | 768,400 |
2021/08/25 | 1,609 | 1,630 | 1,579 | 1,623 | -16 | -1% | 1,806,500 |
2021/08/24 | 1,638 | 1,646 | 1,626 | 1,639 | +1 | +0.1% | 861,600 |
2021/08/23 | 1,625 | 1,644 | 1,625 | 1,638 | +49 | +3.1% | 973,700 |
2021/08/20 | 1,592 | 1,620 | 1,587 | 1,589 | -13 | -0.8% | 887,100 |
751~
800
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム